These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 20738072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Folate receptor-targeted multimodal fluorescence mesosilica nanoparticles for imaging, delivery palladium complex and in vitro G-quadruplex DNA interaction.
    Poshteh Shirani M, Rezaei B, Khayamian T, Dinari M, Karami K, Mehri-Lighvan Z, Hosseini Shamili F, Ramazani M, Alibolandi M.
    J Biomol Struct Dyn; 2018 Dec; 36(16):4156-4169. PubMed ID: 29188757
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
    Lv Y, Cao Y, Li P, Liu J, Chen H, Hu W, Zhang L.
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
    [Abstract] [Full Text] [Related]

  • 6. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.
    Nanotechnology; 2011 Nov 11; 22(45):455102. PubMed ID: 22019849
    [Abstract] [Full Text] [Related]

  • 7. Comparative toxicity of PEG and folate-derived blue-emitting silicon nanoparticles: in vitro and in vivo studies.
    Calienni MN, Lillo CR, Prieto MJ, Gorojod RM, V Alonso SD, Kotler ML, Gonzalez MC, Montanari J.
    Nanomedicine (Lond); 2019 Feb 11; 14(4):375-385. PubMed ID: 30688554
    [Abstract] [Full Text] [Related]

  • 8. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
    Sahoo B, Devi KS, Dutta S, Maiti TK, Pramanik P, Dhara D.
    J Colloid Interface Sci; 2014 Oct 01; 431():31-41. PubMed ID: 24980623
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
    Song Y, Zhou B, Du X, Wang Y, Zhang J, Ai Y, Xia Z, Zhao G.
    Biomed Pharmacother; 2020 May 01; 125():109561. PubMed ID: 32106385
    [Abstract] [Full Text] [Related]

  • 11. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N, Wang Z, Zhang Y, Zhang K, Xie J, Liu Y, Li W, Feng N.
    Artif Cells Nanomed Biotechnol; 2018 May 01; 46(sup2):921-935. PubMed ID: 29790797
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line.
    Erdem M, Yalcin S, Gunduz U.
    Hum Exp Toxicol; 2017 Aug 01; 36(8):833-845. PubMed ID: 27758842
    [Abstract] [Full Text] [Related]

  • 14. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y, Han N, Zhao Q, Bai L, Li J, Jiang T, Wang S.
    Eur J Pharm Sci; 2015 May 25; 72():12-20. PubMed ID: 25701727
    [Abstract] [Full Text] [Related]

  • 15. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P, Tambe P, Paknikar KM, Gajbhiye V.
    Colloids Surf B Biointerfaces; 2017 Aug 01; 156():203-212. PubMed ID: 28531877
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS, Yawata T, Honke K.
    Eur J Pharm Sci; 2014 Feb 14; 52():48-61. PubMed ID: 24178005
    [Abstract] [Full Text] [Related]

  • 18. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
    Hanafi-Bojd MY, Jaafari MR, Ramezanian N, Xue M, Amin M, Shahtahmassebi N, Malaekeh-Nikouei B.
    Eur J Pharm Biopharm; 2015 Jan 14; 89():248-58. PubMed ID: 25511563
    [Abstract] [Full Text] [Related]

  • 19. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
    Saroj S, Rajput SJ.
    Artif Cells Nanomed Biotechnol; 2018 Jan 14; 46(sup3):S1115-S1130. PubMed ID: 30669865
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.